Libby, J. B., Beecham, G., Montine, T. J., Toga, A. W., Cuccaro, M. L., Keene, C. D., Larson, E. B., Crane, P. K., Mukherjee, S., Panizzon, M. S., Biber, S. A., Kukull, W. A., Bennett, D. A., Schneider, J. A., Barnes, L. L., De Jager, P. L., Menon, V., Hohman, T. J., & Dumitrescu, L. C. (2024). Genetically predicted levels of sex hormones are associated with cerebrovascular disease pathology in the Alzheimer’s disease brain. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.092453

Serrano, D., Johansson, H., Bertelsen, B.-E., Gandini, S., Mellgren, G., Thomas, P., Crew, K. D., Kumar, N. B., Macis, D., Aristarco, V., Guerrieri-Gonzaga, A., Lazzeroni, M., D’Amico, M., Buttiron-Webber, T., Briata, I. M., Spinaci, S., Galimberti, V., Vornik, L. A., Villar-Sanchez, E., … DeCensi, A. (2024). Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae183

Gaspard, U., Taziaux, M., Jost, M., Coelingh Bennink, H. J. T., Utian, W. H., Lobo, R. A., & Foidart, J.-M. (2023). A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life. Menopause, 30(5), 480–489. https://doi.org/10.1097/gme.0000000000002167

Oveisgharan, S., Yang, J., Yu, L., Burba, D., Bang, W., Tasaki, S., Grodstein, F., Wang, Y., Zhao, J., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2023). Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology, 100(14). https://doi.org/10.1212/wnl.0000000000206833

Douxfils, J., Gaspard, U., Taziaux, M., Jost, M., Bouvy, C., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (2022). Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women. Climacteric, 26(1), 55–63. https://doi.org/10.1080/13697137.2022.2139599